Closing Bell: Nervgen Pharma Corp up on Friday (NGEN) Automated Summaries - The Globe and Mail - Fri Jul 5, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Jul 5, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp up on Thursday (NGEN) Automated Summaries - The Globe and Mail - Thu Jul 4, 4:01PM CDT
Automated Summaries - The Globe and Mail
Thu Jul 4, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN) Automated Summaries - The Globe and Mail - Wed Jul 3, 4:01PM CDT
Automated Summaries - The Globe and Mail
Wed Jul 3, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp up on Tuesday (NGEN) Automated Summaries - The Globe and Mail - Tue Jul 2, 4:01PM CDT
Automated Summaries - The Globe and Mail
Tue Jul 2, 4:01PM CDT
NervGen Pharma: Stocks Analysts Recently Downgraded on TSX-V (NGEN) AI-generated - The Globe and Mail - Tue Jul 2, 7:42AM CDT
AI-generated - The Globe and Mail
Tue Jul 2, 7:42AM CDT
NervGen Pharma Corp is among the group of TSX Venture Exchange stocks recently downgraded by analysts. This means each stock on this list has seen its averge consensus value drop in the last week so at least one analyst has downgraded their view on these stocks. This report is generated...
Closing Bell: Nervgen Pharma Corp down on Friday (NGEN) Automated Summaries - The Globe and Mail - Mon Jul 1, 4:01PM CDT
Automated Summaries - The Globe and Mail
Mon Jul 1, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp down on Friday (NGEN) Automated Summaries - The Globe and Mail - Fri Jun 28, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Jun 28, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp down on Thursday (NGEN) Automated Summaries - The Globe and Mail - Thu Jun 27, 4:01PM CDT
Automated Summaries - The Globe and Mail
Thu Jun 27, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN) Automated Summaries - The Globe and Mail - Wed Jun 26, 4:01PM CDT
Automated Summaries - The Globe and Mail
Wed Jun 26, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp up on Tuesday (NGEN) Automated Summaries - The Globe and Mail - Tue Jun 25, 4:01PM CDT
Automated Summaries - The Globe and Mail
Tue Jun 25, 4:01PM CDT
NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage Newsfile - Tue Jun 25, 7:34AM CDT
Newsfile
Tue Jun 25, 7:34AM CDT
New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic stroke and ALSVancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, today...
Closing Bell: Nervgen Pharma Corp up on Monday (NGEN) Automated Summaries - The Globe and Mail - Mon Jun 24, 4:01PM CDT
Automated Summaries - The Globe and Mail
Mon Jun 24, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp up on Friday (NGEN) Automated Summaries - The Globe and Mail - Fri Jun 21, 4:02PM CDT
Automated Summaries - The Globe and Mail
Fri Jun 21, 4:02PM CDT
Closing Bell: Nervgen Pharma Corp up on Thursday (NGEN) Automated Summaries - The Globe and Mail - Thu Jun 20, 4:02PM CDT
Automated Summaries - The Globe and Mail
Thu Jun 20, 4:02PM CDT
NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium Newsfile - Thu Jun 20, 7:34AM CDT
Newsfile
Thu Jun 20, 7:34AM CDT
Vancouver, British Columbia--(Newsfile Corp. - June 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced today that Mr. Mike Kelly, President & CEO, will be presenting a corporate update at the 2nd...
Closing Bell: Nervgen Pharma Corp down on Wednesday (NGEN) Automated Summaries - The Globe and Mail - Wed Jun 19, 4:01PM CDT
Automated Summaries - The Globe and Mail
Wed Jun 19, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp down on Tuesday (NGEN) Automated Summaries - The Globe and Mail - Tue Jun 18, 4:01PM CDT
Automated Summaries - The Globe and Mail
Tue Jun 18, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp down on Monday (NGEN) Automated Summaries - The Globe and Mail - Mon Jun 17, 4:02PM CDT
Automated Summaries - The Globe and Mail
Mon Jun 17, 4:02PM CDT
Closing Bell: Nervgen Pharma Corp down on Friday (NGEN) Automated Summaries - The Globe and Mail - Fri Jun 14, 4:01PM CDT
Automated Summaries - The Globe and Mail
Fri Jun 14, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp down on Thursday (NGEN) Automated Summaries - The Globe and Mail - Thu Jun 13, 4:02PM CDT
Automated Summaries - The Globe and Mail
Thu Jun 13, 4:02PM CDT
Closing Bell: Nervgen Pharma Corp up on Wednesday (NGEN) Automated Summaries - The Globe and Mail - Wed Jun 12, 4:02PM CDT
Automated Summaries - The Globe and Mail
Wed Jun 12, 4:02PM CDT
Closing Bell: Nervgen Pharma Corp down on Tuesday (NGEN) Automated Summaries - The Globe and Mail - Tue Jun 11, 4:01PM CDT
Automated Summaries - The Globe and Mail
Tue Jun 11, 4:01PM CDT
Closing Bell: Nervgen Pharma Corp up on Monday (NGEN) Automated Summaries - The Globe and Mail - Mon Jun 10, 4:02PM CDT
Automated Summaries - The Globe and Mail
Mon Jun 10, 4:02PM CDT
Closing Bell: Nervgen Pharma Corp up on Friday (NGEN) Automated Summaries - The Globe and Mail - Fri Jun 7, 4:02PM CDT
Automated Summaries - The Globe and Mail
Fri Jun 7, 4:02PM CDT
NervGen Pharma Grants Stock Options Newsfile - Thu Jun 6, 5:08PM CDT
Newsfile
Thu Jun 6, 5:08PM CDT
Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that the company has granted 950,000 incentive stock options to directors and consultants of the company exercisable...
